April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Measurement and Prediction of Active Pharmaceutical Ingredient Diffusion With and Without Simulated Tear Flow
Author Affiliations & Notes
  • Richard C. Coulon
    Encompass Pharmaceutical Services, Inc, Norcross, Georgia
  • Thomas E. Rowe
    Encompass Pharmaceutical Services, Norcross, Georgia
  • Janet M. Akande
    Encompass Pharmaceutical Services, Inc, Norcross, Georgia
  • Ken Reed
    Belmont University School of Pharmacy, Nashville, Tennessee
  • Mario G. Fsadni
    International Pharm-Med Ltd., Harpenden, United Kingdom
  • Footnotes
    Commercial Relationships  Richard C. Coulon, Encompass (E); Thomas E. Rowe, Encompass (E); Janet M. Akande, Encompass (E); Ken Reed, Encompass (C); Mario G. Fsadni, International Pharm-Med (E)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3234. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Richard C. Coulon, Thomas E. Rowe, Janet M. Akande, Ken Reed, Mario G. Fsadni; Measurement and Prediction of Active Pharmaceutical Ingredient Diffusion With and Without Simulated Tear Flow. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3234.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : In vitro comparison of the effect of formulation changes on the diffusion of drug using a dynamic corneal diffusion model. It has been previously shown that a dynamic diffusion model more accurately describes the impact of formulation variations than a more typical static diffusion model (ARVO 2010 program # 2452). Various retention enhancement formulations were studied to determine the optimum release rate of drug from the various drug matrices.

Methods: : Rabbit corneas were placed on a specially adapted spherical Franz Cells. Samples of various formulations of the API were placed on the cornea. Experiments were performed comparing the new formulations to an aqueous solution formulation. Corneal permeate containing drug in the receiver was collected over time. Samples were also collected through the outlet flow port of the donor compartment representing drug lost through drainage.

Results: : There were significant differences in the diffusion characteristics when comparing the diffusion profile of the solution formulation to those of retention enhanced formulations. Enhanced formulations showed improved cross corneal diffusion even though the formulations contained lower concentrations of API. The combination of the lower amount of drug in the formulation along with the retention enhancement of the formulation resulted in severely reduced amounts of drug eliminated by the action of the simulated tear flow.

Conclusions: : Cross corneal diffusion profiles are an important parameter in predicting ocular drug disposition. This in vitro model was helpful in quickly identifying formulation alternatives which could be selected based on the preferred drug release profile.

Keywords: cornea: tears/tear film/dry eye • cornea: basic science 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.